COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 2953: Articles 29521-29530  | Next

Decline in global COVID-19 transmission
Romero-Severson, E. O., Hengartner, N., Meadors, G., Ke, R.
10.1101/2020.04.18.20070771 — Posted: 2020-04-23
Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses
Makhoul, M., Ayoub, H. H., Chemaitelly, H., Seedat, S., Mumtaz, G. R., Al-Omari, S., Abu-Raddad, L. J.
10.1101/2020.04.19.20070805 — Posted: 2020-04-23 Discussion: Onsite
COVID-19 Asymptomatic Infection Estimation
Yu, Y., Liu, Y.-R., Luo, F.-M., Tu, W.-W., Zhan, D.-C., Yu, G., Zhou, Z.-H.
10.1101/2020.04.19.20068072 — Posted: 2020-04-23 Discussion: Onsite
Cluster of COVID-19 in northern France: A retrospective closed cohort study
Fontanet, A., Tondeur, L., Madec, Y., Grant, R., Besombes, C., Jolly, N., Fernandes Pellerin, S., Ungeheuer, M.-N., Cailleau, I., Kuhmel, L., Temmam, S., Huon, C., Chen, K.-Y., Crescenzo, B., Munier, S., Demeret, C., Grzelak, L., Staropoli, I., Bruel, T., Gallian, P., Cauchemez, S., van der Werf, S., Schwartz, O., Eloit, M., Hoen, B.
10.1101/2020.04.18.20071134 — Posted: 2020-04-23 Discussion: Onsite | Offsite
Is there evidence that BCG vaccination has non-specific protective effects for COVID 19 infections or is it an illusion created by lack of testing?
Shivendu, S., Chakraborty, S., Onuchowska, A., Srivastava, A., Patidar, A.
10.1101/2020.04.18.20071142 — Posted: 2020-04-23
An empirical estimate of the infection fatality rate of COVID-19 from the first Italian outbreak
Rinaldi, G., Paradisi, M.
10.1101/2020.04.18.20070912 — Posted: 2020-04-23 Discussion: Onsite | Offsite
Trends of SARS-Cov-2 infection in 67 countries: Role of climate zone, temperature, humidity and curve behavior of cumulative frequency on duplication time
Berumen, J., Schmulson, M., Guerrero, G., Barrera, E., Larriva-Sahd, J., Olaiz, G., Garcia-Leyva, R., Wong-Chew, R. M., Betancourt-Cravioto, M., Gallardo, H., Fajardo-Dolci, G., Tapia-Conyer, R.
10.1101/2020.04.18.20070920 — Posted: 2020-04-23
Clinical Characteristics of 20,662 Patients with COVID-19 in mainland China: A Systemic Review and Meta-analysis
Tang, C., Zhang, K., Wang, W., Pei, Z., Liu, Z., Yuan, P., Guan, Z., Gu, J.
10.1101/2020.04.18.20070565 — Posted: 2020-04-23
A single-cell atlas of the peripheral immune response to severe COVID-19
Wilk, A. J., Rustagi, A., Zhao, N. Q., Roque, J., Martinez-Colon, G. J., McKechnie, J. L., Ivison, G. T., Ranganath, T., Vergara, R., Hollis, T., Simpson, L. J., Grant, P., Subramanian, A., Rogers, A. J., Blish, C. A.
10.1101/2020.04.17.20069930 — Posted: 2020-04-23 Discussion: Onsite | Offsite
Distinguish Coronavirus Disease 2019 Patients in General Surgery Emergency by CIAAD Scale: Development and Validation of a Prediction Model Based on 822 Cases in China
Zhao, B., Wei, Y., Sun, W., Qin, C., Zhou, X., Wang, Z., Li, T., Cao, H., Wang, W., Wang, Y.
10.1101/2020.04.18.20071019 — Posted: 2020-04-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).